2003
DOI: 10.1016/s0016-5085(03)00384-6
|View full text |Cite
|
Sign up to set email alerts
|

Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
189
0
8

Year Published

2004
2004
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 253 publications
(205 citation statements)
references
References 30 publications
6
189
0
8
Order By: Relevance
“…4 Table 4. Many anticancer drugs derived from plants were useful clinically include vinblastine irinotecan, topotecan and paclitaxel [31,32] . Several biological processes and biological interactions occur between flavonoids, phenolic compounds or polyphenols, with enzymes, proteins that make them toxic to the cell or inhibit the growth of cells [33] .…”
Section: +mentioning
confidence: 99%
“…4 Table 4. Many anticancer drugs derived from plants were useful clinically include vinblastine irinotecan, topotecan and paclitaxel [31,32] . Several biological processes and biological interactions occur between flavonoids, phenolic compounds or polyphenols, with enzymes, proteins that make them toxic to the cell or inhibit the growth of cells [33] .…”
Section: +mentioning
confidence: 99%
“…Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP), with a reported incidence of 1%-10% in most prospective studies [1][2][3][4][5][6][7][8][9] . The generally accepted criteria for the diagnosis of post-ERCP pancreatitis were proposed in 1991 during a consensus workshop.…”
Section: Introductionmentioning
confidence: 99%
“…Pharmacological prevention of post-ERCP pancreatitis has focused on several postulated mechanisms of injury including relaxation of the sphincter of Oddi by calcium channel antagonists [11] and PDE-5 inhibitors [12], interruption of the inflammatory cascade by NSAIDs [13], and inhibition of pancreatic secretion by somatostatin [14] and octreotide [15]. Theoretically, intervention by different agents targeting multiple steps in the pathogenesis of post-ERCP pancreatitis may be more efficient than intervention by a single agent.…”
Section: Discussionmentioning
confidence: 99%